RH
XMUN:RS1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
RH
XMUN:RS1
|
US |
|
K
|
Kalbe Farma Tbk PT
XMUN:LCLA
|
ID |
|
B
|
Baidu Inc
XBER:B1CB
|
CN |
|
E
|
EDP Renovaveis SA
DUS:EDW
|
ES |
|
D
|
Draganfly Inc
F:3U8A
|
CA |
Wall St Price Targets
RS1 Price Targets Summary
RH
According to Wall Street analysts, the average 1-year price target for RS1 is 139.48 EUR with a low forecast of 76.17 EUR and a high forecast of 211.17 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RS1's stock price target?
Price Target
139.48
EUR
According to Wall Street analysts, the average 1-year price target for RS1 is 139.48 EUR with a low forecast of 76.17 EUR and a high forecast of 211.17 EUR.
What is the Revenue forecast for RH?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for RH?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for RH?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for RH?
Projected CAGR
25%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 25%.
What is the Net Income forecast for RH?
Projected CAGR
26%
The compound annual growth rate for Net Income over the next 8 years is 26%.
